Abstract:Beginning in the 1960s, animal and cell culture studies have demonstrated that transcranial photobiomodulation (t-PBM), which involves photons in the red and near-infrared spectrum, can penetrate the cerebral cortex and enhance the mitochondrial electron transport chain [1] (fNIRS similarly uses near infrared photons to image the brain, but at lower light intensities and exposure, resulting in minimal impact on brain function). Emerging human t-PBM data have demonstrated behavioral and clinical effects in multiple patient populations, along with effects on cerebral metabolism and hemodynamics, highlighting its potential therapeutic efficacy [1]. For example, small studies suggested that t-PBM delivered with both high (700 mW/cm 2 ) and low (36 mW/cm 2 ) irradiance [2] is effective in the treatment of major depressive disorder (MDD). However, since other studies with low t-PBM irradiance (55 mW/cm 2 ) did not replicate the positive results in MDD [3], it becomes critically important to further understand the irradiance dose-dependent neurobiological mechanisms of t-PBM, as we are attempting in our ongoing clinical trial [4]. t-PBM has an excellent safety profile [1,2,3], and it can be performed in multiple settings, including during magnetic resonance imaging (MRI) or other neuroimaging modalities, to quantify the impact on brain bioenergetics noninvasively and in real-time. However, work is still underway to determine the optimal parameters for clinical utility. Our team has recently demonstrated the effect of t-PBM, at medium irradiance (300 mW/cm 2 ), on regional intrinsic brain activity in 19 individuals with early Alzheimer's disease [AD] [5]. In this publication [5], we found that t-PBM altered the fractional amplitude of low-frequency fluctuations (fALFF) across all laser-irradiated brain cortical regions, which are limited to frontal regions due to skull density and hair interference. fALFF, assessed non-invasively during resting-state MRI, is a voxel-based measure of intrinsic brain activity measuring the regional brain metabolism: it is strongly correlated with cerebral glucose metabolism measured by [ 18 F]Fluorodeoxyglucose positron emission tomography. Similarly, other studies have reported increases in MRI BOLD signal (also in t-PBM-irradiated brain areas, at 300 mW/cm 2 irradiance) in healthy volunteers [6]. The increase in fALFF we detected in t-PBM-irradiated brain areas during stimulation [5], and the similar increases in MRI BOLD signal [6], suggest that t-PBM can increase intrinsic brain activity (and specifically cerebral metabolism) in real time; these effects continue briefly after t-PBM administration has ended.

Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction

Transcranial photobiomodulation increases cognition and serum BDNF levels in adults over 50 years: A randomized, double-blind, placebo-controlled trial

Effects of transcranial photobiomodulation on peripheral biomarkers associated with oxidative stress and complex IV activity in the prefrontal cortex in rats subjected to chronic mild stress

Dose-dependent effects of transcranial photobiomodulation on brain temperature in patients with major depressive disorder: a spectroscopy study

Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics

Transcranial low-level laser stimulation in near infrared-II region for brain safety and protection

Transcranial photobiomodulation for neurodevelopmental disorders: a narrative review

Transcranial Low-Level Laser Stimulation in the Near-Infrared-ii Region (1064 Nm) for Brain Safety in Healthy Humans

Transcranial photobiomodulation in children aged 2–6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology

Effects of Pulsed Red and Near-Infrared Light on Neuroblastoma Cells—Pilot Study on Frequency and Duty Cycle

Brain photobiomodulation therapy on neurological and psychological diseases

Transcranial near-infrared light in treatment of neurodegenerative diseases

Photobiomodulation and the brain: a new paradigm

Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics

Pulsed Transcranial Photobiomodulation Generates Distinct Beneficial Neurocognitive Effects Compared with Continuous Wave Transcranial Light

0378 A Randomized, Sham-Controlled Pilot Trial of a Novel Near-Infrared Phototherapy Device on Sleep and Daytime Function

Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy

Photobiomodulation increases brain metabolic activity through a combination of 810 and 660 wavelengths: a comparative study in male and female rats

Photobiomodulation improves depression symptoms: a systematic review and meta-analysis of randomized controlled trials

Transcranial Photobiomodulation (tPBM) as Alzheimer's Therapy

Photobiomodulation with near-infrared laser for tinnitus management: preliminary animal experiments and randomized clinical trials